Usher Syndrome Type 1b clinical trials

Explore recruiting usher syndrome type 1b clinical trials.

Recruiting usher syndrome type 1b studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Usher Syndrome Type 1b trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label study to determine the long-term safety, tolerability and biological activity of SAR421869 in patients with Usher syndrome Type 1B

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2 Multicenter, Open-label, Dose Escalation, Safety and Efficacy Study of Subretinal Administration of Dual AAV8.MYO7A, AAVB-081 in Participants with Usher Syndrome Type 1B (USH1B) Retinitis Pigmentosa

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Usher Syndrome Type 1b trials by city

Usher Syndrome Type 1b in Toronto Usher Syndrome Type 1b in Vancouver Usher Syndrome Type 1b in Montreal Usher Syndrome Type 1b in Calgary Usher Syndrome Type 1b in Edmonton Usher Syndrome Type 1b in Ottawa Usher Syndrome Type 1b in Winnipeg Usher Syndrome Type 1b in Quebec City Usher Syndrome Type 1b in Hamilton Usher Syndrome Type 1b in Kitchener Usher Syndrome Type 1b in London Usher Syndrome Type 1b in Halifax Usher Syndrome Type 1b in New York Usher Syndrome Type 1b in Los Angeles Usher Syndrome Type 1b in Chicago Usher Syndrome Type 1b in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease